Zyversa Therapeutics Eulerpool Ziņas

Zyversa Therapeutics Eulerpool News

Zyversa Therapeutics Akciju Ziņas

Zyversa Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Zyversa Therapeutics ziņas mēs apkopojam šeit.

• 3. septembris ·

  Seeking Alpha
  ZyVersa Therapeutics files for mixed shelf offering
• 3. septembris ·

  Thefly.com
  ZyVersa Therapeutics files $100M mixed securities shelf
• 9. augusts ·

  Yahoo
  ZyVersa Therapeutics Reports Second Quarter, 2024 Financial Results and Provides Business Update
• 9. augusts ·

  InvestorPlace
  ZVSA Stock Earnings: ZyVersa Therapeutics Beats EPS for Q2 2024
• 9. augusts ·

  Seeking Alpha
  ZyVersa Therapeutics GAAP EPS of -$3.31 beats by $0.44
• 7. augusts ·

  Yahoo
  ZyVersa Therapeutics Announces Published Data Supporting the Rationale for Inhibiting Inflammasome ASC with IC 100 to Control Chronic Inflammation
• 7. augusts ·

  Thefly.com
  ZyVersa Therapeutics announces publication of data on extracellular ASC
• 29. jūlijs ·

  Yahoo
  ZyVersa Therapeutics Announces Published Data Demonstrating That Plasma Levels of Inflammasome ASC Show Promise as Biomarker of Early Cognitive Changes in Older Adults
• 29. jūlijs ·

  Thefly.com
  ZyVersa Therapeutics announces publication of data on inflammasome ASC
• 25. jūlijs ·

  Yahoo
  ZyVersa Therapeutics Selects Obesity and Related Metabolic Complications as Lead Indication for Inflammasome ASC Inhibitor IC 100